Acute Kidney Injury Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What combination of drivers is leading to accelerated growth in the acute kidney injury market?
The rising prevalence of diabetes is projected to boost the acute kidney injury market. Diabetes is a group of metabolic disorders characterized by high blood sugar levels due to insufficient insulin production or cellular resistance to insulin. The rising number of diabetes cases is attributed to factors such as increasing obesity rates, poor dietary habits, sedentary lifestyles, aging populations, and improved diagnosis and awareness. Acute kidney injury plays a role in metabolic and inflammatory changes, which can impact insulin resistance and glucose regulation, creating a complex interaction that affects diabetes management. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the proportion of individuals with type 1 diabetes receiving all eight recommended care processes rose by 22%, while for type 2 diabetes, it increased by 21%. Additionally, the percentage achieving target HbA1c levels reached 37.9%, marking the highest value ever recorded by the National Diabetes Audit (NDA). Therefore, the rising prevalence of diabetes is driving the acute kidney injury market.

Get Your Acute Kidney Injury Market Report Here:
https://www.thebusinessresearchcompany.com/report/acute-kidney-injury-global-market-report

What is the projected compound annual growth rate (CAGR) of the acute kidney injury market from 2025 to 2034, and what factors influence it?
The acute kidney injury market has witnessed significant expansion in recent years. It is expected to grow from $5.37 billion in 2024 to $5.74 billion in 2025, achieving a CAGR of 6.9%. The primary drivers of past growth include the rising prevalence of chronic diseases, an aging population, increasing hospital-acquired infections, growing awareness of kidney health, and advancements in critical care medicine.

The acute kidney injury market size is poised for significant expansion in the next few years. By 2029, it is expected to reach $7.39 billion, growing at a compound annual growth rate (CAGR) of 6.5%. The projected growth is driven by a rising prevalence of sepsis, increasing demand for personalized treatment, growing government healthcare initiatives, higher healthcare expenditures in emerging markets, and an increased focus on personalized medicine and regenerative therapies. Key trends in this period include the development of wearable dialysis devices, the use of artificial intelligence in treatment optimization, advancements in portable renal replacement therapy systems, continuous renal replacement therapy (CRRT) improvements, the integration of remote monitoring, and broader adoption of telemedicine.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21079&type=smp

How are the latest trends influencing the growth of the acute kidney injury market?
In the acute kidney injury (AKI) market, companies are striving for regulatory approvals to expand their product portfolios and offer novel treatment options. For example, Mission Therapeutics Ltd., a UK-based biotechnology company, received FDA approval in December 2023 to initiate a Phase II clinical trial for its lead asset MTX652. This trial focuses on patients at high risk for AKI following cardiac surgery and explores the potential of MTX652 to reduce kidney damage and promote recovery.

What are the major segments of the acute kidney injury market and their role in driving growth?
The acute kidney injury market covered in this report is segmented -

1) By Injury: Pre-Renal Kidney Injury, Post-Renal Kidney Injury, Intrinsic Kidney Injury
2) By Treatment Type: Dialysis, Drug Therapy, Urinary Implants
3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Pre-Renal Kidney Injury: Hypovolemia, Heart Failure-Related Injury, Sepsis-Induced Injury, Renal Artery Stenosis, Hepatorenal Syndrome
2) By Post-Renal Kidney Injury: Ureteral Obstruction, Bladder Outlet Obstruction, Prostate Enlargement (Benign Prostatic Hyperplasia), Kidney Stones, Tumors Affecting Urinary Tract
3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN), Acute Interstitial Nephritis (AIN), Glomerulonephritis, Vasculitis, Rhabdomyolysis-Induced Injury

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21079

Which regions are key players in the growth of the acute kidney injury market?
North America was the largest region in the acute kidney injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute kidney injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the acute kidney injury market?
Major companies operating in the acute kidney injury market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co. Ltd., Teva Pharmaceutical Industries Ltd., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co. Ltd., Quark Pharmaceuticals Inc., Kringle Pharma Inc., Aptabio Therapeutics Inc., Alexion Pharmaceuticals Inc., Alloksys Life Sciences B.V., AM-Pharma B.V., Arch Biopartners Inc., Guard Therapeutics International AB

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21079&type=smp

What Is Covered In The Acute Kidney Injury Global Market Report?

•Market Size Forecast: Examine the acute kidney injury market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the acute kidney injury market for a structured understanding.
•Key Players Overview: Analyze major players in the acute kidney injury market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the acute kidney injury market.
•Segment Contributions: Evaluate how different segments drive overall growth in the acute kidney injury market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the acute kidney injury market.
•Industry Challenges: Identify potential risks and obstacles affecting the acute kidney injury market.
•Competitive Landscape: Review strategic developments in the acute kidney injury market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.